Goldenwell Biotech Stock Market Value
| GWLL Stock | USD 0.20 0.00 775.00% |
| Symbol | Goldenwell |
Goldenwell Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Goldenwell Biotech's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Goldenwell Biotech.
| 10/31/2025 |
| 01/29/2026 |
If you would invest 0.00 in Goldenwell Biotech on October 31, 2025 and sell it all today you would earn a total of 0.00 from holding Goldenwell Biotech or generate 0.0% return on investment in Goldenwell Biotech over 90 days. Goldenwell Biotech is related to or competes with Grupo KUO, RCL Foods, Zinzino AB, Ausnutria DairyLtd, Select Harvests, Perusahaan Perkebunan, and Origin Enterprises. Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States More
Goldenwell Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Goldenwell Biotech's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Goldenwell Biotech upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.17) | |||
| Maximum Drawdown | 74.89 | |||
| Value At Risk | (14.29) |
Goldenwell Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Goldenwell Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Goldenwell Biotech's standard deviation. In reality, there are many statistical measures that can use Goldenwell Biotech historical prices to predict the future Goldenwell Biotech's volatility.| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (1.95) | |||
| Total Risk Alpha | (2.68) | |||
| Treynor Ratio | 2.02 |
Goldenwell Biotech January 29, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.12) | |||
| Market Risk Adjusted Performance | 2.03 | |||
| Mean Deviation | 4.88 | |||
| Coefficient Of Variation | (589.69) | |||
| Standard Deviation | 11.69 | |||
| Variance | 136.57 | |||
| Information Ratio | (0.17) | |||
| Jensen Alpha | (1.95) | |||
| Total Risk Alpha | (2.68) | |||
| Treynor Ratio | 2.02 | |||
| Maximum Drawdown | 74.89 | |||
| Value At Risk | (14.29) | |||
| Skewness | (1.69) | |||
| Kurtosis | 20.94 |
Goldenwell Biotech Backtested Returns
Goldenwell Biotech holds Efficiency (Sharpe) Ratio of -0.17, which attests that the entity had a -0.17 % return per unit of risk over the last 3 months. Goldenwell Biotech exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Goldenwell Biotech's Standard Deviation of 11.69, risk adjusted performance of (0.12), and Market Risk Adjusted Performance of 2.03 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of -0.99, which attests to possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Goldenwell Biotech are expected to decrease slowly. On the other hand, during market turmoil, Goldenwell Biotech is expected to outperform it slightly. At this point, Goldenwell Biotech has a negative expected return of -1.98%. Please make sure to check out Goldenwell Biotech's value at risk, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Goldenwell Biotech performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.15 |
Insignificant predictability
Goldenwell Biotech has insignificant predictability. Overlapping area represents the amount of predictability between Goldenwell Biotech time series from 31st of October 2025 to 15th of December 2025 and 15th of December 2025 to 29th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Goldenwell Biotech price movement. The serial correlation of 0.15 indicates that less than 15.0% of current Goldenwell Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.15 | |
| Spearman Rank Test | -0.32 | |
| Residual Average | 0.0 | |
| Price Variance | 0.32 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetOther Information on Investing in Goldenwell Pink Sheet
Goldenwell Biotech financial ratios help investors to determine whether Goldenwell Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Goldenwell with respect to the benefits of owning Goldenwell Biotech security.